VitalSigns Technology
ECG Anytime and anywhere
VitalSigns was founded in Taiwan, 2016 , focusing on the ECG related software and hardware design service and was elected the TOP-5 smart-medical cooperation in Taiwan.
CVD is the major death cause of the world. VitalSigns Technology is trying to provide people a better way to known our own cardiovascular system via our wearable ECG devices and diagnosis and monitor software.
VitalSigns provides wearable ECG device with FDA certification and diagnosis software to help doctors make the best decision. for life saving.
VitalSigns are a digital healthcare company providing a real-time ECG measurement approach for clinically diagnosis on CVD by combining our wearable ECG device with LTE biosensor gateway and deep-learning capabilities Cloud AI diagnosis.
Our goal is to be the leading provider of real-time ECG monitoring.
The global ECG patch and Holter monitor market size was valued at USD 797.9 million in 2019 and is expected to expand at a CAGR of 17.5% from 2020 to 2027 (2.8B) . The growing prevalence of atrial fibrillation, aging, and rising incidence of cardiovascular disorders are likely to drive the market for ECG patch and Holter monitor during the forecast period.
There are at least 0.1 % population (CLASS-I) shall receive the PTCA, CABG surgery every year. The patient shall take at least 2 week2 to 6 weeks post surgery real-time ECG care. that will generate more than 1M tests that generate 1.8B market opportunity.
The ambulatory cardiac monitoring market is well-established with an estimated 4.6 million diagnostic tests (CLASS-II) performed annually in the United States for the symptomatic test.
The first two class are existed market that is what we try to build. For post-COVID-19, Realtime-ECG monitoring becomes even more important for decreasing the hospital visits of high risk patient group.
iRhythm and AliveCor are the leading companies og ECG monitor service
